Frederico Freitas

Scientist at TCR2 Therapeutics - Cambridge, MA, US

Frederico Freitas's Contact Details
HQ
617-949-5200
Location
Company
TCR2 Therapeutics
Frederico Freitas's Company Details
TCR2 Therapeutics logo, TCR2 Therapeutics contact details

TCR2 Therapeutics

Cambridge, MA, US • 250 - 499 Employees
BioTech/Drugs

TCR² Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors. The company is focused on the discovery and development of product candidates against novel and complex targets utilizing its proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells). The TRuC platform is designed to specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). For more information about TCR², please visit www.tcr2.com.

Cancer therapy T cell biology Immunology Molecular biology Biotech Biotech
Details about TCR2 Therapeutics
Frequently Asked Questions about Frederico Freitas
Frederico Freitas currently works for TCR² Therapeutics Inc..
Frederico Freitas's role at TCR² Therapeutics Inc. is Scientist.
Frederico Freitas's email address is ***@tcr2.com. To view Frederico Freitas's full email address, please signup to ConnectPlex.
Frederico Freitas works in the Biotechnology industry.
Frederico Freitas's colleagues at TCR2 Therapeutics are Troy Patterson, Lindsay Hock, Charlotte Chapman, Sofia Spyrou, Michele Davison, Meguel Sousa, Urvi Ph.D. and others.
Frederico Freitas's phone number is 617-949-5200
See more information about Frederico Freitas